Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Medical Affairs Resources, Structures and Trends

Published by: Best Practices, LLC

Published: Jul. 1, 2009 - 45 Pages


Table of Contents


RESEARCH OVERVIEW

Research Objective

Definitions

KEY FINDINGS

RESEARCH PARTICIPANTS

MEDICAL AFFAIRS STRUCTURE & ORGANIZATION

Medical Affairs Structure

Medical Affairs Organization

Medical Affairs Reporting

Medical Affairs Leadership

Medical Affairs Global Span

MEDICAL AFFAIRS RESOURCES

Medical Affairs Spending

Medical Affairs Spending Increases

Medical Affairs Staff Increases

Increasing Medical Affairs Resources

Decreasing Medical Affairs Resources

MEDICAL AFFAIRS TRENDS

Importance of Medical Affairs Functions

Median Outsourcing Expenses

Impact of FDA Revitalization Act on Medical Affairs

SUCCESS FACTORS & TOP CHALLENGES

Success Factors

Medical Affairs Challenges

APPENDIX: PARTICIPANT DEMOGRAPHICS AND COMPLETE

SURVEY RESPONSES

List of Participating Companies

Job Titles of Participants

Number of Therapeutic Areas Supported

Number of Compounds/Products Supported

Annual Sales Revenue for Participating Companies

Success Factors

Key Challenges

Reasons for Increasing Medical Affairs Resources

Reasons for Decreasing Medical Affairs Resources

Reasons for Increasing Importance of Medical Affairs

Reasons for Declining Importance of Medical Affairs

About Best Practices, LLC

Abstract

STUDY OVERVIEW

Charged with building and maintaining physician relationships, pharmaceutical Medical Affairs organizations typically oversee several important functions - including publications, KOL programs, grants, and medical education (CME) that have been impacted in recent years by a call for increased transparency. As such, forward-looking biopharmaceutical executives are beginning to evaluate Medical Affairs operations to ensure that the vital organization is appropriately structured and resourced to operate effectively in the current environment.

This Best Practices, LLC study explores how U.S. and global biopharmaceutical companies are structuring and managing their Medical Affairs organizations today. The study also examines recent trends in budget and staffing resources, key challenges and top success factors for the function. Pharmaceutical, biotech and medical device managers and executives will be able to use this research to determine how their Medical Affairs organizations compare with industry benchmarks.

KEY TOPICS
  • Organizational Structure
  • Reporting Relationship
  • Job Level of Group Leader
  • Geographic Span
  • Budget Allocation by Medical Affairs Function
  • Percent of Budget Allocated for Outsourcing
  • Recent and Anticipated changes in Resource Levels
  • Impact of Medical Affairs Functions on Company Success
  • Key Success Factors for Medical Affairs
  • Key Challenges for Medical Affairs
KEY METRICS
  • Type of structure (centralization)
  • Medical Affairs group dedication
  • Departmental reporting relationships
  • Job level or Medical Affairs head
  • Geographic span of organization
  • Percentage of spending per Medical Affairs function
  • Directional trends in staffing levels
  • Reasons cited for budget/staff increases
  • Reasons cited for budget/staff decreases
  • Relative importance of seven different Medical Affairs functions
  • Reasons cited for increased importance
  • Reasons cited for decreased importance
  • Percentage of budget allocated for outsourcing
  • Percent of companies impacted by FDA Revitalization Act
  • Top three success factors for developing and maintaining effective Medical Affairs group
  • Top three challenges for developing and maintaining effective Medical Affairs group
METHODOLOGY

The research involved an online survey of 26 Medical Affairs at 25 leading pharmaceutical, biotechnology and medical device companies

INDUSTRIES PROFILED

Biotech; Pharmaceutical; Consumer Products; Diagnostic; Manufacturing; Health Care

COMPANIES PROFILED

Amgen; Astellas; AstraZeneca Pharmaceuticals; Bayer Schering AG; Bayer; Auxillium; Becton Dickinson; Bristol-Myers Squibb; Cubist Pharmaceuticals; Esteve; Genentech; Johnson & Johnson; Myriad; Novartis; Novo Nordisk; Pfizer; Schering-Plough; Solvay Pharmaceuticals; Vertex Pharmaceuticals; ApoPharma; OctoPlus; Procaps; Savient; SK&F; Werrick

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report

Price and Delivery Options
See related reports or call the number above for help from a research specialist.


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009